The federal government has signed two letters of intent with foreign healthcare companies to enhance healthcare access and capacity in Nigeria.

The ministry of health and social welfare disclosed this in a statement issued in Abuja on Sunday, by the deputy director, information and public relations, Alaba Balogun.

According to the statement, the agreements involve Siemens Healthineers’ Nigerian partner, Tanit Medical Engineering, and Abbott Laboratories GmbH.

The Memorandum of Understanding (MoU) outlines the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) and reaffirms the federal government’s commitment to improving healthcare delivery through public-private partnerships.

The partnerships aim to boost the assembly of ultrasound systems, enhance medical training for Nigerian professionals, and strengthen the self-sufficiency of the national healthcare system.

They will also guarantee access to high-quality, locally produced diagnostic solutions.

Abdu Mukhtar, national coordinator of PVAC, represented the federal government in signing the agreements, with the coordinating minister of health and social welfare, Muhammad Pate, in attendance.

The statement quoted Mr Mukhtar as saying that the agreement demonstrated PVAC’s commitment to reducing reliance on imports and enhancing future access to medical devices.

“This MoU embodies our shared vision for advancing healthcare, improving access, outcomes, and unlocking the potential of Nigeria’s healthcare value chain,” he added.

Mr Pate commended Mr Mukhtar and his team for attracting investors to Nigeria and explained the Executive Order that provided incentives for those investing in the health sector.

Kevin Massoudi, vice president and head of public sector engagement for Siemens Healthineers in the Middle East and Africa, reaffirmed Siemens’ dedication to advancing diagnostic services in Nigeria.

He emphasised the company’s commitment to supporting the country’s healthcare sector.

Mr Massoudi also highlighted Nigeria’s pivotal role as a leader in health innovation across the African continent.

He recognised the nation’s influence and potential to drive progress in the field of healthcare.

Dr Rabah El Menshawy, vice president of EMEA and Global Accounts at Abbott Laboratories GmbH, highlighted the forward-thinking leadership of President Bola Tinubu, whose ambitious vision laid the foundation for a brighter future in Nigeria’s healthcare sector.

He added, “This commitment ensures that Nigerians can access high-quality diagnostic solutions, proudly produced here in Nigeria.

“We are inspired by this vision and are honoured to partner in its realisation.

“Our collaboration also focuses on supporting Nigeria’s goal of ending HIV infections by 2030, which aligns with our mission to promote health equity and empower individuals to lead healthier, fuller lives.

“Through this MoU, Abbott aims to enhance healthcare delivery in Nigeria by improving access to quality diagnostics, thereby contributing to the overall health and well-being of the Nigerian people.” 

(NAN)